SENSEX
NIFTY
GOLD
USD/INR

Weather

image 10    C

Science/Tech News

The Hindu News

Science/Tech / The Hindu

details

What hinders Indian pharma companies from making drugs for rare diseases

Challenges include complex regulations, prohibitive costs and conventional, non-innovative trial designs. Changes to clinical trial rules to accommodate flexible trial designs, bringing in AI and simplifying approval processes could go a long way toward promoting new drug R&D in India

30 Dec 2025 10:00 am